Roche Holding AG Company Description

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania.

The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions.

It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology.

Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Roche Holding AG

Country	Switzerland
Founded	1896
Industry	Drug Manufacturers - General
Sector	Healthcare
Employees	103,605
CEO	Thomas Schinecker

Contact Details

Address: Grenzacherstrasse 124 Basel, 4058 Switzerland
Phone	41 61 688 11 11
Website	roche.com

Stock Details

Ticker Symbol	RO
Exchange	SIX Swiss Exchange
Fiscal Year	January - December
Reporting Currency	CHF
ISIN Number	CH0012032113
SIC Code	2834

Key Executives

Name	Position
Dr. Thomas Schinecker	Chief Executive Officer
Dr. Severin Schwan Ph.D.	Executive Chairman
Dr. Alan Hippe	Chief Financial and Information Officer
Dr. Bruno Eschli	Head of Investor Relations
Claudia Bockstiegel	General Counsel
Pascale Schmidt	Chief Compliance Officer
Barbara Schadler	Head of Group Communications
Cristina A. Wilbur	Chief People Officer
Dr. Nicolas Dunant	Head of Group Media Relations
Boris L. Zaitra	Head of Corporate Business Development